Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  UCB SA    UNC   BE0003739530

UCB SA (UNC)

0
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Deutsche Boerse Ag
06/23/2015 06/24/2015 06/25/2015 06/26/2015 06/29/2015 Date
65.2(c) 65.329(c) 65.784(c) 65.789(c) 65.263(c) Last
4 0 0 0 95 Volume
+2.15% +0.20% +0.70% +0.01% -0.80% Change
More quotes
Financials (€)
Sales 2015 3 650 M
EBIT 2015 516 M
Net income 2015 283 M
Debt 2015 1 492 M
Yield 2015 1,75%
Sales 2016 3 938 M
EBIT 2016 659 M
Net income 2016 392 M
Debt 2016 1 332 M
Yield 2016 1,88%
PER 2015 36,61
PER 2016 30,42
EV / Sales 2015 3,89x
EV / Sales 2016 3,57x
Capitalization 12 711 M
More Financials
Company
UCB SA is a biopharmaceutical company that engages in the research, development and commercialization of innovative drugs in the fields of central nervous system and immunology disorders.It focuses on the discovery and development of innovative medicines and solutions to transform the lives of... 
Sector
Pharmaceuticals
Calendar
07/31Earnings Release
More about the company
Surperformance© ratings of UCB SA
Trading Rating : Investor Rating :
More Ratings
Latest news on UCB SA
06/24 CIPLA : Lupin readies Rs7,500 cr chest for buyouts
06/01 CIPLA : LUPIN, CIPLA BID FOR UCB's $1 BILLION US GENERICS UNIT
06/01 Lupin, cipla bid for ucb's $1 billion generics unit
05/27 UCB : Patent Issued for Pharmaceutical Composition Comprising Rotigotine Salts (..
05/04 UCB : ex-dividend day for annual dividend
04/02 DR REDDY LABORATORIES : Labs to Acquire Brands Portfolio of UCB for USD128 Milli..
03/30 Ireland's Horizon to buy U.S. drugmaker Hyperion for $1.1 billion
03/27 UCB : Convening notice to attend the general meeting of shareholders
More news
Sector news : Biopharmaceuticals
08:31a ZOETIS : to Host Webcast and Conference Call on Second Quarter 2015 Financial Re..
07:25a MERCK : MSD's Cardiovascular Safety Trial of JANUVIA (sitagliptin), Met Primary ..
06:25a KANGMEI PHARMACEUTICAL : Gets Holding Expansion
More sector news : Biopharmaceuticals
Comments 
Advertisement
Chart UCB SA
Duration : Period :
UCB SA Technical Analysis Chart | UNC | BE0003739530 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions